Researchers have successfully applied a novel PET/CT technique to characterize the effects of a gene therapy intervention in animal models, demonstrating its potential for improving cardiac health. The study showed that successful transfer of a VEGF gene resulted in increased tissue perfusion without impairing cardiac function.
David M. Goldenberg, a pioneer in radiolabeled antibodies, has received the Society of Nuclear Medicine's 2005 Paul C. Aebersold Award. He has developed antibodies for various cancer types and therapies, making significant contributions to nuclear medicine.
Larson, a leading expert in targeted radiotherapy and molecular imaging, has made significant contributions to the advancement of positron emission tomography (PET) as a clinical tool for oncology. His research has led to novel findings in cancer understanding and treatment.
David James Brooks, a pioneer in applying PET to movement disorders, received the Kuhl-Lassen Award for his groundbreaking research on Parkinson's and related disorders. His work has improved understanding of disease progression, diagnosis, and therapeutics.
Researchers used PET/CT scans to evaluate nearly 2,000 cancer patients and detected unexpected additional malignancies. These newly identified lesions are often of early stage and have a better likelihood of being cured if treated promptly and aggressively.
Small animal imaging allows for repeated, non-invasive studies on the same living subject, providing crucial information on disease progression and treatment outcomes. This technology enables researchers to gain insights into human biology and disease, leading to improved diagnosis and development of innovative drugs.
Researchers used PET/CT to diagnose foot infections in diabetics by detecting glucose uptake with labeled radiotracer 18F-FDG. This approach facilitated better localization of infection and structural changes in bone and soft tissues, showing promise for more accurate diagnoses.
The study used combined PET and MRI to track cocaine pharmacokinetics in pregnant nonhuman primates. The results showed that cocaine accumulated at the highest levels in the liver, and to a lesser extent in the brain, suggesting a unique anatomy of fetal circulation.
Researchers have developed a new fluorine-18 labeled imaging agent, nifrolidine, which binds to a receptor involved in cognition and learning. This receptor is also linked to nicotine addiction and lung cancer, making it a potential target for early Alzheimer's disease diagnosis and treatment.
The Journal of Nuclear Medicine Supplement offers a comprehensive overview of radionuclide therapy, including its applications in thyroid cancer, lymphoma, and other diseases. The supplement highlights the growing importance of nuclear medicine in patient care and provides insight into emerging trends and technologies.
The study found that PET/CT imaging was effective in detecting new malignancy and precisely localizing disease extent in patients with suspected occult recurrent cancer. The imaging modality provided valuable information for treatment planning, potentially avoiding further invasive procedures.
A study using combined positron emission tomography and computed tomography may help detect early abnormalities in the arterial wall, potentially useful for early disease detection, prevention, and prognosis. Nuclear medicine could provide valuable information on plaque composition.
A study by Johannes Schwarz and colleagues tracked molecular changes in brains of Parkinson's patients over 7.5 years using SPECT to measure dopamine transporter binding, revealing a single exponential decline rather than linear loss. This advancement enables the development of individualized treatment for advanced Parkinson's patients.
Researchers in The Netherlands and Belgium developed a new technique that uses genetically engineered rhTSH to stimulate thyroid cancer cells to absorb radioactive iodine, avoiding hypothyroidism and increasing safety. This approach may allow higher doses of radioiodine to be used when needed, improving treatment efficacy.
PET scans improved detecting distant metastases with an accuracy of 85%, compared to 55% for current standard diagnostics. The technique also showed high accuracy in diagnosing locoregional disease, surpassing current practice by 24 percentage points.
A study using FDG-PET imaging found that brain metabolic activity increases in response to food stimulation, making it harder for those more sensitive to food to diet. The findings may lead to innovative treatment options for eating disorders.
Researchers discovered a correlation between FDG uptake in PET scans and degree of plaque inflammation in patients with moderate to high-grade carotid stenoses. The study's findings offer hope for improving stroke risk prediction and developing new plaque-stabilizing drugs.
Researchers used SPECT imaging to measure dopamine transporter binding in 18 adult ADHD patients. Those with high levels of binding showed significant improvement on Ritalin, while those with reduced binding did not respond to the drug.
Researchers developed a new cancer treatment combining radioimmunotherapy with conventional chemotherapy, achieving complete remission in 72% of patients with follicular non-Hodgkin's lymphoma. The approach may improve treatment outcomes by targeting remaining cancer cells after chemotherapy.
Researchers use 18F-FDDNP-PET to measure tangles and plaques in brain, providing valuable information on disease status. The technique accurately separates AD patients from control subjects, offering opportunities for early diagnosis and monitoring treatment effects.
Researchers in Japan used PET to differentiate between infected and non-infected vascular grafts, confirming its accuracy in diagnosing graft infections. The study's findings suggest that PET studies can safely and specifically identify patients who need treatment for graft infection.
A new study using combined PET/CT imaging has effectively diagnosed diabetes-related osteomyelitis of the foot. The technique provides a precise location of infection, enabling easier treatment strategy definition and improved patient outcomes.
A new technique using hybrid scanners combines PET and CT to diagnose coronary artery disease, providing a precise picture of the heart's function. This method is more accurate than traditional diagnostic methods and may relieve patients from invasive procedures.
Researchers used a custom-built small animal imaging system to demonstrate gene expression in mice with cystic fibrosis. The results show promise for novel gene delivery methods and potential treatments for the debilitating disease.
Researchers developed a sequential radioimmunotherapy and chemotherapy approach, achieving a 75% overall response rate and 90% complete remission rate in patients with advanced mantle cell lymphoma. The study's findings suggest this novel treatment may be a promising advance for the disease.
A study using FMISO-PET scans found that high uptake of the tracer correlates with a greater risk of tumor recurrence, while low uptake is associated with a longer survival rate. The technique may enable more precise prediction of therapeutic outcomes and improved patient treatment.
A new combined PET/CT scanner has shown significant improvement in tumor staging accuracy compared to traditional CT and PET imaging methods. The study involved 260 patients with various oncological diseases, yielding accurate staging results in 84% of cases.
Researchers at University of Texas Southwestern Medical Center developed a new SPECT imaging test that can accurately diagnose Alzheimer's disease in its early stages. The test identifies reduced blood flow in the posterior cingulate cortex, allowing doctors to identify AD patients significantly sooner than current methods.
A new study supports the use of PET scans in early diagnosis of Alzheimer's disease, particularly in its early stages. The study identifies a new PET technique that can clearly identify brain connections altered by Alzheimer's, leading to higher accuracy in diagnosing the condition.
Researchers have discovered a novel approach to combat Cryptococcus neoformans and Histoplasma capsulatum, two fungi responsible for serious diseases. Radioimmunotherapy (RIT) utilizes designer antibodies coupled with radioactive isotopes to deliver targeted radiation, demonstrating superior efficacy over external gamma radiation.
A study published in The Journal of Nuclear Medicine found that PET scans are more effective than CT scans in early assessment of patients' responses to imatinib mesylate therapy. The researchers concluded that 18F-FDG PET is an excellent prognostic tool for predicting treatment response in gastrointestinal stromal tumors.
A new dynamic PET technique has been developed to provide more accurate diagnoses and improve patient comfort during PET scans. By combining a short initial scan with a longer static scan, doctors can gather valuable data about cancer tumors and treatment response.
Researchers found decreased tumor blood flow correlated significantly with survival in patients treated with neoadjuvant chemotherapy. The study suggests tumor biology should be an important factor in considering patient response to treatment.
A study published in The Journal of Nuclear Medicine found that 18F-FLT PET scans are more accurate than 18F-FDG PET scans in differentiating between cancerous and non-cancerous lung tumors. However, the researchers noted that 18F-FDG is still a reliable tool for staging tumors.
A recent study has found that 18F-FDG PET scans are more accurate than CT scans in predicting post-therapy Hodgkin's disease relapse. The diagnostic accuracy of 18F-FDG PET was 92%, while CT results were only correct in 56% of cases.
The study found that rhTSH reduced the mean effective half-life of radioiodine by 26% in patients who received it before therapy. This reduction allowed patients to clear 131I more rapidly, resulting in lower radiation levels in their blood and tissues.
The study showed that FDHT-PET detected osseous lesions in patients with advanced metastatic prostate cancer, confirming its utility in evaluating prostate cancer patients. The test also revealed the presence of additional lymph node lesions not identified by CT scans, suggesting its potential to predict response to hormone therapy.
FDG PET demonstrates high accuracy for diagnosing infection and inflammation, with a sensitivity of 93% and specificity of 84%, according to a study analyzing 844 scans on 806 patients.
A PET scan study found that only a combination of methylphenidate and a behavioral stimulus resulted in increased dopamine levels. The increases were associated with improved perception of the task as interesting and motivating.
The microPET Focus offers significant improvements in image resolution and system sensitivity compared to its predecessor. The new design features reduced detector crystal cross-sections and gap sizes, resulting in improved spatial resolution and increased sensitivity.
Researchers used microPET and optical CCD imaging to track transplanted rat cardiac cells, detecting higher uptake in areas where cells were transplanted compared to background tissues. This study provides valuable insight into cell transplant biology, enabling real-time monitoring of engrafted cells.
A study by Joanna Fowler and colleagues found significant reductions in MAO B activity in the heart, lungs, kidneys, and spleen of smokers compared to non-smokers, with reductions ranging from 33 to 46%. The findings suggest that smoking impacts peripheral organs and highlight the need for further examination of these consequences.
A study by Dr. Pio and colleagues found that FLT-PET imaging outperforms FDG-PET in predicting tumor response to chemotherapy in breast cancer patients. The researchers compared the two imaging modalities in 11 newly diagnosed patients, taking scans before treatment began, after the first dose, and following the final cycle.
A new study suggests radiosynoviorthesis is effective in treating osteoarthritis, providing significant pain relief to 2/3 of patients with proven synovitis. The procedure, which involves removing inflamed membrane using beta-emitting radionuclides, shows promise as a treatment option for OA.
FDHT PET detected 46 lesions, outperforming conventional methods, which identified 59. The agent rapidly absorbed in metastatic lesions indicating functioning androgen receptors. Notably, FDHT uptake reduced in patients starting testosterone therapy.
The Society of Nuclear Medicine has announced an image that represents a significant advance in achieving high throughput in PET scanning without sacrificing quality. The image showcases technology such as 3D-LSO PET/CT, which could decrease whole-body scan duration substantially, benefiting nuclear medicine professionals and patients.
A study using PET scans found that schizophrenics have elevated dopamine receptor levels in both basal forebrain and SN/VTA areas of the brain. Differences were observed in cortical dopamine levels, supporting the hypothesis of dysregulated neurotransmission leading to abnormal regulation of neurons.
The study found that intracoronary infusion of progenitor cells after acute myocardial infarction (AMI) significantly increased mean signal intensity (MSI) in areas with AMI damage, regardless of the type of progenitor cells used. The treatment showed a positive effect on myocardial viability.
A study found that PET-CT scans were more accurate than PET scans alone in staging non-small cell lung cancer patients. The combined imaging technique correctly identified lung cancer with chest wall and vascular spread, downgrading tumor severity in 13.3% of cases.
Researchers compared MPI and CCTA scans to determine a more comprehensive assessment of coronary artery disease. Combining functional SPECT MPI and anatomic CT scans provided valuable information on severe myocardial perfusion defects and calcium deposits.